ReviewInternational journal of cardiology. Congenital heart disease2022
Sudden cardiac death in adults with congenital heart disease: Lessons to Learn from the ATROPOS registry.
Review in International journal of cardiology. Congenital heart disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sudden cardiac death (SCD) is one of the most frequent causes of death in adult patients with congenital heart disease (ACHD). Despite the rare frequency of its occurrence, the incident appears often when unexpected, and many affected patients had not been identified priorly. Data on predictors for SCD are limited since the total number of ACHD is low. As the cohort is heterogeneous, it is difficult to define uniform risk factors that apply to all ACHD. Complexity of the congenital heart disease appears to play a role, but other factors may also be relevant and have not been sufficiently identified yet. In current guidelines, recommendations are primarily based on data of patients without congenital heart disease. With the ATROPOS registry, we are aiming to identify reliable risk factors for SCD. The registry enables physicians globally to include patients with congenital heart disease who died of or survived SCD. After acquisition, the data will be compared to an age and complexity of disease matched cohort to perform a case-control analysis. Subsequently, a further analysis will be performed using deep learning algorithms with artificial intelligence to amplify the gathered information and find reliable risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.